BIOREM Inc.
BRM.V
TSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 125.35% | -59.66% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 125.35% | -59.66% | |||
| Cost of Revenue | 94.52% | -50.56% | |||
| Gross Profit | 245.45% | -76.51% | |||
| SG&A Expenses | 75.39% | -43.48% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 91.86% | -49.22% | |||
| Operating Income | 1,327.09% | -95.19% | |||
| Income Before Tax | 869.95% | -92.61% | |||
| Income Tax Expenses | 888.21% | -91.27% | |||
| Earnings from Continuing Operations | 863.54% | -92.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 863.54% | -92.98% | |||
| EBIT | 1,327.09% | -95.19% | |||
| EBITDA | 891.28% | -92.97% | |||
| EPS Basic | 856.67% | -93.52% | |||
| Normalized Basic EPS | 863.16% | -93.17% | |||
| EPS Diluted | 835.44% | -93.66% | |||
| Normalized Diluted EPS | 841.79% | -93.23% | |||
| Average Basic Shares Outstanding | 0.44% | 8.49% | |||
| Average Diluted Shares Outstanding | 2.72% | 9.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||